Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression

Zhu, Yu, Herndon, John M., Sojka, Dorothy K., Kim, Ki-Wook, Knolhoff, Brett L., Zuo, Chong, Cullinan, Darren R., Luo, Jingqin +7 more·2017·Immunity
DOI 10.1016/j.immuni.2017.08.018

Cited by (180)

Items 101–180 of 180

  1. The Impact of the Cancer Microenvironment on Macrophage Phenotypes
    Sunyoung Ham, Luize Goncalves Lima, Erica S. H. Lek, Andreas Möller · 2020 · Frontiers in Immunology
  2. Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention
    Hancheng Wu, Jing Li, Ruilin Yao, Jing Liu, Lili Su, Wenjie You · 2025 · Theranostics
  3. Brain metastasis models: What should we aim to achieve better treatments?
    Mariam Masmudi‐Martín, Lucía Zhu, Macarena Sánchez‐Navarro, Neibla Priego, María Casanova-Acebes, Victor Ruiz‐Rodado, Ernest Giralt, Manuel Valiente · 2020 · Advanced Drug Delivery Reviews
  4. Tissue-resident macrophage inflammaging aggravates homeostasis dysregulation in age-related diseases.
    Ziqi Yue, L. Nie, Peng Zhang, Qin Chen, Q. Lv, Qi Wang · 2020 · Cellular Immunology
  5. Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression
    Viktoria Plackoska, Dania Shaban, Anastasia Nijnik · 2022 · Frontiers in Immunology
  6. Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances
    Jan Brancewicz, Paulina Kucharzewska · 2025 · Frontiers in Immunology
  7. Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
    Wenting Du, Marina Pasca di Magliano, Yaqing Zhang · 2021 · Frontiers in Oncology
  8. TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function
    Muhammad Shamsul Alam, Matthias M. Gaida, Hagen Roland Witzel, Shizuka Otsuka, Aamna J. Abbasi, Theresa M. Guerin, Abdalla Amr Abdelmaksoud, Nathan W. Wong, Maggie Cam, Serguei Kozlov et al. · 2024 · Cell Reports Medicine
  9. Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy
    Jing Zhou, Yuexu Jiang, Yue Huang, Qiongling Wang, Jussuf T. Kaifi, Eric T. Kimchi, Chiswili Yves Chabu, Zhenguo Liu, Trupti Joshi, Guangfu Li · 2021 · Translational Oncology
  10. S100A11: A Potential Carcinogen and Prognostic Marker That Correlates with the Immunosuppressive Microenvironment in Pan-Cancer
    Xiaozhen Ji, Xin Yu Qin, Xiuming Huang, Wei Wang, Huiyan Li, Chuizhi Zheng, Yanjing Huang · 2023 · Journal of Cancer
  11. Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme
    Vasiliki Koliaraki, Ana Raquel Henriques, Alejandro Prados, George A. Kollias · 2020 · The Journal of Experimental Medicine
  12. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing
    Karin Zins, Dietmar Abraham · 2020 · Methods in molecular biology
  13. An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy
    Yuta Izumi, Masashi Kanayama, Zhongchuzi Shen, Masayuki Kai, Shunsuke Kawamura, Megumi Akiyama, Masahide Yamamoto, Toshikage Nagao, Keigo Okada, Norihiko Kawamata et al. · 2021 · Frontiers in Immunology
  14. The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets
    Hirotake Tsukamoto, Yoshihiro Komohara, Hiroyuki Oshiumi · 2021 · Human Cell
  15. Spon1+ inflammatory monocytes promote collagen remodeling and lung cancer metastasis through lipoprotein receptor 8 signaling
    Kristina Marinak Whately, Nisitha Sengottuvel, Lincy Edatt, Sonal Srivastava, Allison T Woods, Yi‐Hsuan Tsai, Alessandro Porrello, Matthew P. Zimmerman, Aaron C Chack, Stuart R. Jefferys et al. · 2024 · JCI Insight
  16. BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer
    Brian E. Diskin, Salma Adam, Gustavo Sanchez Soto, Miguel Liria, Berk Aykut, Belen Sundberg, Eric H. Li, Joshua Leinwand, Ruonan Chen, Mirhee Kim et al. · 2022 · Oncogene
  17. Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
    Jessica Waibl Polania, Emily Lerner, Daniel S. Wilkinson, Alexandra M. Hoyt-Miggelbrink, Peter Edward Fecci · 2021 · Frontiers in Immunology
  18. Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks
    Kelvin K. Tsai, Tze‐Sian Chan, Yuval Shaked · 2019 · Journal of Clinical Medicine
  19. Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancers
    Dandan Li, Udo Rudloff · 2025 · Expert Opinion on Emerging Drugs
  20. Stromal regulation of tumor-associated lymphatics
    Hafsa Munir, Corrado Mazzaglia, Jacqueline D. Shields · 2020 · Advanced Drug Delivery Reviews
  21. Autofluorescence identifies highly phagocytic tissue-resident macrophages in mouse and human skin and cutaneous squamous cell carcinoma
    Pierre Bourdely, Luciana Petti, Sokchea Khou, Aïda Meghraoui, Roxane Elaldi, Julie Cazareth, Noushin Mossadegh‐Keller, Julien Boyer, Michael H. Sieweke, Gilles Poissonnet et al. · 2022 · Frontiers in Immunology
  22. Pirfenidone alleviates fibrosis by acting on tumour–stroma interplay in pancreatic cancer
    Yalan Lei, Jin Xu, Mingming Xiao, Di Wu, He Xu, Jing Yang, Xiaoqi Mao, Haoqi Pan, Xianjun Yu, Si Shi · 2024 · British Journal of Cancer
  23. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies
    Songyu Guo, Zhenxia Wang · 2024 · Frontiers in Oncology
  24. Tumor-associated macrophages in canine visceral hemangiosarcoma
    Mikael Kerboeuf, Didrik Andreas Haugeberg, Tobias Olsen, Linn Kaia Sørling, Erling Olaf Koppang, Lars Moe, Anita Haug Haaland · 2023 · Veterinary Pathology
  25. Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches
    Angelo Aquino, Ornella Franzese · 2025 · Cancers
  26. Early Life Inflammation and the Developing Hematopoietic and Immune Systems: The Cochlea as a Sensitive Indicator of Disruption
    Kelly Otsuka, Christopher Nielson, Matthew A. Firpo, Albert H. Park, Anna E. Beaudin · 2021 · Cells
  27. Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis
    Joana E. Aggrey-Fynn, Meghana Manjunath, Ashish Rajput, Amro M. Abdelrahman, Julia Thiel, Mark Joseph Truty, Andrew G. Clark, Meng Dong, Steven A. Johnsen · 2025 · Cell Death and Disease
  28. Nano-delivery of Gemcitabine Derivative as a Therapeutic Strategy in a Desmoplastic KRAS Mutant Pancreatic Cancer
    Manisit Das, Jun Li, Michelle Bao, Leaf Huang · 2020 · The AAPS Journal
  29. Targeting tumor-associated CCR2 + macrophages to inhibit pancreatic cancer recurrence following irreversible electroporation
    Weichen Xu, Shaoyue Li, Xuexia Shan, Qiao Wang, Xinhua Chen, Shengbo Wu, Yincheng Gao, Dan-Dan Shan, Shi-Si Ding, Weiwei Ren et al. · 2025 · Science Advances
  30. Therapeutic targeting of tumour-associated macrophage receptors
    Rosa Gomes Alves Martins, Mehmet M Tekin, Mark Steven Cragg, Ali Roghanian · 2024 · Immunotherapy Advances
  31. Modulation of infiltrating CD206 + macrophages restricts progression of pulmonary lymphangioleiomyomatosis
    Heng-Jia Liu, Rémi Diesler, Joelle Chami, Boxiang Wu, Heng Du, Yue Jin, Melissa Daou, Nicola Alesi, Damir Khabibullin, Caroline Leroux et al. · 2025 · European Respiratory Journal
  32. Dynamic remodeling of amino acid metabolism in tumor-associated macrophages: Fueling immunosuppression, reshaping tumor niches, and unlocking metabolic checkpoints
    Beibei Ran, Lingjun Xiao, Yan Liu, Chenglin Zhang, Lingkai Kong, Yuxin Zhang, Xiaosong Gu, Chunping Jiang, Junhua Wu · 2025 · Journal of Advanced Research
  33. IRF8 Governs Tumor-Associated Macrophage Control of T Cell Exhaustion
    Briana G. Nixon, Fengshen Kuo, Ming Liu, Kristelle J. Capistrano, Mytrang Do, Ruth A. Franklin, Xiaodi Wu, Emily R. Kansler, Raghvendra Mohan Srivastava, Tanaya A. Purohit et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  34. PI3Kγ in Tumour Inflammation: Bridging Immune Response and Cancer Progression—A Mini‐Review
    Anghesom Ghebremedhin, Judith A. Varner · 2025 · Immunology
  35. Targeting the Tumor Immune Microenvironment in Triple-Negative Breast Cancer: The Promise of Polyphenols
    Aaron L. Hilliard, Tanya D. Russell, Patricia Mendonca, Karam F. A. Soliman · 2025 · Cancers
  36. Pan-Cancer Single-Cell RNA Sequencing Analysis Refines Multi-Origin Monocyte and Macrophage Lineages
    Truc Do Thanh. Nguyen, Andrew Lee, Hyun Jung Park, Nameeta Shah, Bayrta Mandzhieva, Dong‐Sup Lee, Inkyung Jung, Woong‐Yang Park · 2025 · Cancer Immunology Research
  37. Mechano-regulation of cancer cell memory in tumor progression and therapy
    Yunjia Qu, Jiaxin Cui, Zhiang Wu, Peixiang He, Fan Wei, Tianze Guo, Yixuan Huang, Xi Yu, Mishel Tsoy, Kunshu Liu et al. · 2025 · Mechanobiology in Medicine
  38. Inflammation drives age-induced loss of tissue resident macrophages
    Kémy Adé, Javier Saenz Coronilla, Dorian Obino, Tobias Weinberger, Caroline Kaiser, Sébastien Mella, Cheng Chen, Lida Katsimpardi, Catherine Werts, Han Li et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer
    Caronni, Nicoletta, Montaldo, Elisa, Mezzanzanica, Luca, Cilenti, Francesco, Genua, Marco, Ostuni, Renato · 2021 · Immunological Reviews
  40. Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer
    Renzo Emanuel Vera, María Julia Lamberti, Alina L. González, Martín E. Fernández-Zapico · 2024 · Pancreatology
  41. The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of Mice
    Ana S. Leal, Karen T. Liby · 2024 · International Journal of Molecular Sciences
  42. Macrophages inhibit and enhance endometriosis depending on their origin
    Chloe Hogg, Panir, Kavita, Priya Dhami, Matthew Rosser, Matthias Mack, Daniel Y. H. Soong, Jeffrey W. Pollard, S. Jenkins, Andrew W. Horne, Erin Greaves · 2021 · University of Regensburg Publication Server (University of Regensburg)
  43. The origin and polarization of Macrophages and their role in the formation of the Pre-Metastatic niche in osteosarcoma
    Guisen Lai, Xinyi Zhao, Yuanquan Chen, Tianwei Xie, Zepeng Su, Jiajie Lin, Keng Chen, Keng Chen · 2025 · International Immunopharmacology
  44. Peripheral nerve resident macrophages are microglia-like cells with tissue-specific programming
    Peter L Wang, Aldrin Kay‐Yuen Yim, Ki-Wook Kim, Denis R. Avey, Rafael Sanguinetti Czepielewski, Marco Colonna, Jeffrey Milbrandt, Gwendalyn J. Randolph, The Immunological Genome Project · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  45. An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions
    Jialing Zhang, Stephan Stanislaw Späth, Sherman M. Weissman, Samuel G. Katz · 2019 · Methods in molecular biology
  46. Advances in Antitumor Strategies Targeting Tumor-Associated Macrophages
    枫 杨 · 2022 · World Journal of Cancer Research
  47. Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits
    Chiara Vitale, Andrea Petretto, Katia Cortese, Sonia Carta, Alessandra Dondero, Chiara Lavarello, Davide Cangelosi, Martina Morini, Francesca Bellora, Pietro Arnaldi et al. · 2025 · OncoImmunology
  48. Role of innate immunity in the development of cancer immunotherapy immune-mediated adverse events
    Álvaro Sierra-Salazar, Yatzil Reyna-Juárez, Beatriz Alcalá‐Carmona, Rodrigo Quintana-Tenorio, Jennifer Tiaré Balderas-Miranda, Johan Camacho-Pérez, Jiram José Torres-Ruiz · 2026 · Frontiers in Immunology
  49. Disarming the “Neural Hijack”: Repurposing neuroactive drugs for cancer therapy
    Ming-Zhu Jin, Hao-Ran Dang, Wei-Lin Jin · 2026 · Pharmacology & Therapeutics
  50. LOXL2 in pancreatic tumourigenesis: the complexity of tumour–stromal crosstalk exemplified
    Seth B. Coffelt, Jennifer P. Morton · 2022 · Gut
  51. Establishment of a prognostic prediction system based on tumor microenvironment of pancreatic cancer
    Yan Feng, Pengcheng Li, Fang Yang, Ke Xu · 2022 · Medicine
  52. A 3D multi-compartment assembloid to study combined immune cell infiltration and cytotoxicity
    Eban A. Hanna, Ashleigh J. Crawford, Wenxuan Du, Adrian C. Johnston, David Schell, Zeqi Wan, Ting-Hsi Chen, Fan Wu, Kehan Ren, Yeongseo Lim et al. · 2026 · Cell Reports Methods
  53. YBX1 takes actions on triggering M2-like polarization of macrophages and stabilizing CXCL8 mRNA to exhibit its metastatic potential in bladder cancer
    Huihui Yang, Chuanchi Zhou, Zheng Zhou, Fan Zhang, Liang Tong · 2026 · International Immunopharmacology
  54. Sex differences in innate immune cell responses: Impact on cancer immunity and response to therapy
    Sina Ramin, Terry R. Medler · 2026 · Frontiers in Immunology
  55. Tumor Microenvironment Complexity: A Pathological Milieu that Innately Modulates Cancer Progression
    Liliana-Roxana Balahura, Andreea Daniela Lazăr, Sorina Dinescu, Marieta Costache · 2022 · Springer eBooks
  56. Tumor-Associated Myeloid Cells in Cancer Progression
    Tamara Gulić, Rita Silva-Gomes, Sadaf Davoudian, Marina Sironi, Paola Allavena, Alberto Mantovani, Barbara Bottazzi · 2020 · Springer eBooks
  57. Macrophages can either inhibit or enhance endometriosis depending on their origin
    Chloe Hogg, Priya Dhami, M. Rosser, M. Mack, D. Soong, J. Pollard, S. Jenkins, A. Horne, E. Greaves · 2020 · bioRxiv
  58. Spatial Biology and Organoid Technologies Reveal a Potential Therapy-Resistant Cancer Stem Cell Population in Pancreatic Ductal Adenocarcinoma
    Pritha Adhikary, Jayati L. Chakrabarti, Saptarshi Mallick, Xi Sun, Ugonna Ezuma-Igwe, Abigail G. Branch, Jiang Wang, Nicolas Braissand, Megan P. Corbett, Sangmin Kim et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Obstruction of Capillaries by circulating large Monocytes causes Multi Organ Dysfunction Syndrome (MODS) in Acute Pancreatitis
    Anika Wilden, Juliane Glaubitz, Oliver Otto, Doreen Biedenweg, Matthias A. Nauck, Matthias Mack, Silvia Ribback, Barbara M. Bröker, Sabrina Freiin von Rheinbaben, Markus M. Lerch et al. · 2021 · Research Square
  60. Harnessing the power of trained immunity in the setting of pancreatic cancer: a novel mechanism of immune trafficking and tumor control.
    Anne E. Geller · 2021
  61. Macrophages and their antitumor activity
    Zhixia Zhou · 2022 · Elsevier eBooks
  62. The role of breast cancer derived-exosomes in the tumour micro-environment
    Sunyoung Ham · 2021 · Queensland University of Technology
  63. Phenotypic and functional diversity of tumor-associated macrophages
    Diletta Di Mitri, Alberto Mantovani, Federica Marchesi · 2024 · Elsevier eBooks
  64. Intraductal Papillary Mucinous Neoplasm Cellular Plasticity is Linked with Repeat Element Dysregulation
    Amaya Pankaj, Michael J. Raabe, M. Lisa Zhang, Yuhui Song, Bidish K. Patel, Katherine Xu, Joshua R. Kocher, Evan Lang, Peter Richieri, Nicholas J. Caldwell et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Tumor Microenvironment Complexity: A Pathological Milieu That Innately Modulates Cancer Progression
    Liliana-Roxana Balahura, Andreea Daniela Lazăr, Sorina Dinescu, Marieta Costache · 2025 · Springer eBooks
  66. TAMs-derived IL-1β inducing DDX21 enhances CRC proliferation and metastasis via JAK2/STAT3 pathway
    Yu Wang, Tiantian Zhen, Shujin He, Yuting Wang, Lin Chen, Yongyu Chen, Huijuan Shi, Anjia Han · 2025 · Cancer Treatment and Research Communications
  67. ADAM17-dependent Autocrine and Paracrine Signaling Promotes Pancreatic Premalignant Progression
    Hui-Ju Wen, Erick T. Davis, Jacee S. Moore, Sydney M. Brender, Simone Benitz, Allison M. Wombwell, Ian M. Loveless, Daniel W. Long, Daniel James Salas-Escabillas, Justin Lee et al. · 2025 · Cellular and Molecular Gastroenterology and Hepatology
  68. A macrophage-derived noncanonical WNT niche drives immune exclusion in pancreatic cancer
    Na Hyun Kim, Young Min Song, San Sung Kwon, Sang Hyub Lee, Eun Na Kim, Jung Joo Hong, Seung Hyeok Seok, Yi Rang Na · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Absence of Interstitial Cells of Cajal in Human Colonic Muscularis Mucosae: Implications for Mucosal Motility Control.
    M. Rusu, D. Pirici, Ivan Varga, M. Nicolescu · 2026 · Annals of Anatomy
  70. Interleukin-1 receptor type 1 in pancreatic cancer progression and metastasis: a review
    Kenta Saito, Yoichi Matsuo, Yuki Denda, Keisuke Nonoyama, Hiromichi Murase, Tomokatsu Kato, Yushi Yamakawa, Takafumi Sato, Hiroyuki Sagawa, Ryo Ogawa et al. · 2026 · International Journal of Clinical Oncology
  71. Targeting Prolyl 3-hydroxylase 1 inhibits pancreatic cancer progression and macrophage immunity
    Panzhu Bai, Chengmin Liu, Changying Fu, Renwei Cai, Yanyan Ding, Meiling Quan, Yuhao Ye, Zimo Zhang, Yuan Li, Yanfen Xu et al. · 2026 · Nature Communications
  72. Caractérisation ontogénique, phénotypique et fonctionnelle des cellules dendritiques et des macrophages dans les carcinomes épidermoïdes cutanés
    Pierre Bourdely · 2017 · theses.fr (ABES)
  73. L'activité kinase de FAK dans les fibroblastes associés au cancer : régulateur clé de la progression de l'adénocarcinome pancréatique canalaire
    Sonia Zaghdoudi · 2019 · theses.fr (ABES)
  74. Activation des lymphocytes T gamma delta dans les cancers
    Chloé Laplagne · 2020 · theses.fr (ABES)
  75. Characterization of tumor-infiltrating myeloid cells in a mouse model of melanoma : roles of IL-4Rα signaling and tumor cell immunogenicity
    Elodie Baudoin · 2021 · theses.fr (ABES)
  76. Kupffer Cell Maintenance in Tissue Repair and Ageing
    Kémy Adé · 2021 · theses.fr (ABES)
  77. Role of the early stage stroma-immune interactions in the tumor microenvironment of pancreatic adenocarcinoma
    Zhichong Wu · 2021
  78. An IL-34–IGF-1 inflammatory axis fuels KRAS-mutant lung cancer progression
    Jaroslav Žák, Hui Chen, Erpei Wang, Patrick Ozark, Giuliana P. Mognol, MATTHEW Dae-Young PARK, Nadine Fournier, Priyanka Chaudary, Jingjing Hu, Ryan M. Shepard et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Mitochondrial regulation of tumor-associated macrophage function
    Jiabao Xu, Yangtao Liu, Hongjie Zhang, Zhao Yuan, Yu Sheng, Xiaodong Wang, Hanbin Liu, Fei Zhong, Hui Zhang, Han Xiong et al. · 2026 · Frontiers in Immunology
  80. Integrated single-cell and proteomic profiling of pancreatic neoplasia identifies tissue markers that outperform established diagnostic markers in distinguishing cancer from precursor lesions
    Thoa T Tran, Hoang Phuong Uyen Nguyen, Johannes F. Fahrmann, Duy Truong Pham, Loan Bui, Nhat Huy Bui, Christian Max Schmidt · 2026 · medRxiv